ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of March

March 29, 2013

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995

Von Eschenbach’s Proposal for Plan B Fails to Impress Democrats, Angers Social Conservatives.

August 4, 2006

Cancer Training Programs Fairing Fairley Well

December 1, 1989

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990